{"id":1059,"date":"2007-02-13T07:44:58","date_gmt":"2007-02-12T23:44:58","guid":{"rendered":"http:\/\/www.chinacsr.com\/2007\/02\/13\/1059-amdl-hopes-for-china-approval-of-anti-cancer-drug\/"},"modified":"2007-02-13T07:44:58","modified_gmt":"2007-02-12T23:44:58","slug":"amdl-hopes-for-china-approval-of-anti-cancer-drug","status":"publish","type":"post","link":"https:\/\/www.chinacsr.com\/en\/2007\/02\/13\/1059-amdl-hopes-for-china-approval-of-anti-cancer-drug\/","title":{"rendered":"AMDL Hopes For China Approval Of Anti-Cancer Drug"},"content":{"rendered":"<p>AMDL, a developer of tests for the early detection of cancer and other serious diseases, says that Jade Pharmaceuticals, its wholly-owned subsidiary in China, has set up production and applied for China State Food and Drug Administration approval to market Docetaxel in China.<!--more--><\/p>\n<p>Docetaxel is an anti-cancer drug that interferes with the growth of cancer cells.<\/p>\n<p>\"There is an enormous need in China for effective and affordable cancer drugs, with more than 1.6 million new cases of the disease annually,\" said Gary Dreher, AMDL CEO. \"Docetaxel is extremely useful because it can treat a broad spectrum of cancers, including breast cancer, non-small cell lung cancer, stomach cancer and prostate cancer.\"<\/p>\n<p>According to the company, Docetaxel currently generates more than US$2 billion in sales globally at a rate increasing 20% annually. This drug currently represents approximately US$200 million in sales in China.<\/p>\n<p>According to Dreher, Docetaxel is currently the most popular anticancer drug in China.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>AMDL, a developer of tests for the early detection of cancer and other serious diseases, says that Jade Pharmaceuticals, its wholly-owned subsidiary in China, has set up production and applied for China State Food and Drug Administration approval to market Docetaxel in China.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[8],"tags":[],"class_list":["post-1059","post","type-post","status-publish","format-standard","hentry","category-health"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>AMDL Hopes For China Approval Of Anti-Cancer Drug - ChinaCSR.com - Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China<\/title>\n<meta name=\"description\" content=\"AMDL, a developer of tests for the early detection of cancer and other serious diseases, says that Jade Pharmaceuticals, its wholly-owned subsidiary in\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.chinacsr.com\/en\/2007\/02\/13\/1059-amdl-hopes-for-china-approval-of-anti-cancer-drug\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AMDL Hopes For China Approval Of Anti-Cancer Drug - ChinaCSR.com - Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China\" \/>\n<meta property=\"og:description\" content=\"AMDL, a developer of tests for the early detection of cancer and other serious diseases, says that Jade Pharmaceuticals, its wholly-owned subsidiary in\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.chinacsr.com\/en\/2007\/02\/13\/1059-amdl-hopes-for-china-approval-of-anti-cancer-drug\/\" \/>\n<meta property=\"og:site_name\" content=\"ChinaCSR.com\" \/>\n<meta property=\"article:published_time\" content=\"2007-02-12T23:44:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.chinacsr.com\/en\/wp-content\/uploads\/chinacsr-logo-large.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"620\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"CSR and Sustainability Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@China_CSR\" \/>\n<meta name=\"twitter:site\" content=\"@China_CSR\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"CSR and Sustainability Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.chinacsr.com\/en\/2007\/02\/13\/1059-amdl-hopes-for-china-approval-of-anti-cancer-drug\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.chinacsr.com\/en\/2007\/02\/13\/1059-amdl-hopes-for-china-approval-of-anti-cancer-drug\/\"},\"author\":{\"name\":\"CSR and Sustainability Editor\",\"@id\":\"https:\/\/www.chinacsr.com\/en\/#\/schema\/person\/144aee0ef9221d5da7dba67851ea5cba\"},\"headline\":\"AMDL Hopes For China Approval Of Anti-Cancer Drug\",\"datePublished\":\"2007-02-12T23:44:58+00:00\",\"dateModified\":\"2007-02-12T23:44:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.chinacsr.com\/en\/2007\/02\/13\/1059-amdl-hopes-for-china-approval-of-anti-cancer-drug\/\"},\"wordCount\":160,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.chinacsr.com\/en\/#organization\"},\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.chinacsr.com\/en\/2007\/02\/13\/1059-amdl-hopes-for-china-approval-of-anti-cancer-drug\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.chinacsr.com\/en\/2007\/02\/13\/1059-amdl-hopes-for-china-approval-of-anti-cancer-drug\/\",\"url\":\"https:\/\/www.chinacsr.com\/en\/2007\/02\/13\/1059-amdl-hopes-for-china-approval-of-anti-cancer-drug\/\",\"name\":\"AMDL Hopes For China Approval Of Anti-Cancer Drug - ChinaCSR.com - Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China\",\"isPartOf\":{\"@id\":\"https:\/\/www.chinacsr.com\/en\/#website\"},\"datePublished\":\"2007-02-12T23:44:58+00:00\",\"dateModified\":\"2007-02-12T23:44:58+00:00\",\"description\":\"AMDL, a developer of tests for the early detection of cancer and other serious diseases, says that Jade Pharmaceuticals, its wholly-owned subsidiary in\",\"breadcrumb\":{\"@id\":\"https:\/\/www.chinacsr.com\/en\/2007\/02\/13\/1059-amdl-hopes-for-china-approval-of-anti-cancer-drug\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.chinacsr.com\/en\/2007\/02\/13\/1059-amdl-hopes-for-china-approval-of-anti-cancer-drug\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.chinacsr.com\/en\/2007\/02\/13\/1059-amdl-hopes-for-china-approval-of-anti-cancer-drug\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.chinacsr.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AMDL Hopes For China Approval Of Anti-Cancer Drug\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.chinacsr.com\/en\/#website\",\"url\":\"https:\/\/www.chinacsr.com\/en\/\",\"name\":\"ChinaCSR.com\",\"description\":\"Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China\",\"publisher\":{\"@id\":\"https:\/\/www.chinacsr.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.chinacsr.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.chinacsr.com\/en\/#organization\",\"name\":\"ChinaCSR.com\",\"url\":\"https:\/\/www.chinacsr.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.chinacsr.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.chinacsr.com\/en\/wp-content\/uploads\/chinacsr-logo-large.jpg\",\"contentUrl\":\"https:\/\/www.chinacsr.com\/en\/wp-content\/uploads\/chinacsr-logo-large.jpg\",\"width\":800,\"height\":620,\"caption\":\"ChinaCSR.com\"},\"image\":{\"@id\":\"https:\/\/www.chinacsr.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/China_CSR\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.chinacsr.com\/en\/#\/schema\/person\/144aee0ef9221d5da7dba67851ea5cba\",\"name\":\"CSR and Sustainability Editor\",\"sameAs\":[\"http:\/\/www.chinacsr.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AMDL Hopes For China Approval Of Anti-Cancer Drug - ChinaCSR.com - Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China","description":"AMDL, a developer of tests for the early detection of cancer and other serious diseases, says that Jade Pharmaceuticals, its wholly-owned subsidiary in","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.chinacsr.com\/en\/2007\/02\/13\/1059-amdl-hopes-for-china-approval-of-anti-cancer-drug\/","og_locale":"en_US","og_type":"article","og_title":"AMDL Hopes For China Approval Of Anti-Cancer Drug - ChinaCSR.com - Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China","og_description":"AMDL, a developer of tests for the early detection of cancer and other serious diseases, says that Jade Pharmaceuticals, its wholly-owned subsidiary in","og_url":"https:\/\/www.chinacsr.com\/en\/2007\/02\/13\/1059-amdl-hopes-for-china-approval-of-anti-cancer-drug\/","og_site_name":"ChinaCSR.com","article_published_time":"2007-02-12T23:44:58+00:00","og_image":[{"width":800,"height":620,"url":"https:\/\/www.chinacsr.com\/en\/wp-content\/uploads\/chinacsr-logo-large.jpg","type":"image\/jpeg"}],"author":"CSR and Sustainability Editor","twitter_card":"summary_large_image","twitter_creator":"@China_CSR","twitter_site":"@China_CSR","twitter_misc":{"Written by":"CSR and Sustainability Editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.chinacsr.com\/en\/2007\/02\/13\/1059-amdl-hopes-for-china-approval-of-anti-cancer-drug\/#article","isPartOf":{"@id":"https:\/\/www.chinacsr.com\/en\/2007\/02\/13\/1059-amdl-hopes-for-china-approval-of-anti-cancer-drug\/"},"author":{"name":"CSR and Sustainability Editor","@id":"https:\/\/www.chinacsr.com\/en\/#\/schema\/person\/144aee0ef9221d5da7dba67851ea5cba"},"headline":"AMDL Hopes For China Approval Of Anti-Cancer Drug","datePublished":"2007-02-12T23:44:58+00:00","dateModified":"2007-02-12T23:44:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.chinacsr.com\/en\/2007\/02\/13\/1059-amdl-hopes-for-china-approval-of-anti-cancer-drug\/"},"wordCount":160,"commentCount":0,"publisher":{"@id":"https:\/\/www.chinacsr.com\/en\/#organization"},"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.chinacsr.com\/en\/2007\/02\/13\/1059-amdl-hopes-for-china-approval-of-anti-cancer-drug\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.chinacsr.com\/en\/2007\/02\/13\/1059-amdl-hopes-for-china-approval-of-anti-cancer-drug\/","url":"https:\/\/www.chinacsr.com\/en\/2007\/02\/13\/1059-amdl-hopes-for-china-approval-of-anti-cancer-drug\/","name":"AMDL Hopes For China Approval Of Anti-Cancer Drug - ChinaCSR.com - Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China","isPartOf":{"@id":"https:\/\/www.chinacsr.com\/en\/#website"},"datePublished":"2007-02-12T23:44:58+00:00","dateModified":"2007-02-12T23:44:58+00:00","description":"AMDL, a developer of tests for the early detection of cancer and other serious diseases, says that Jade Pharmaceuticals, its wholly-owned subsidiary in","breadcrumb":{"@id":"https:\/\/www.chinacsr.com\/en\/2007\/02\/13\/1059-amdl-hopes-for-china-approval-of-anti-cancer-drug\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.chinacsr.com\/en\/2007\/02\/13\/1059-amdl-hopes-for-china-approval-of-anti-cancer-drug\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.chinacsr.com\/en\/2007\/02\/13\/1059-amdl-hopes-for-china-approval-of-anti-cancer-drug\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.chinacsr.com\/en\/"},{"@type":"ListItem","position":2,"name":"AMDL Hopes For China Approval Of Anti-Cancer Drug"}]},{"@type":"WebSite","@id":"https:\/\/www.chinacsr.com\/en\/#website","url":"https:\/\/www.chinacsr.com\/en\/","name":"ChinaCSR.com","description":"Corporate Social Responsibility (CSR), Business Intelligence, and Sustainability News for China","publisher":{"@id":"https:\/\/www.chinacsr.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.chinacsr.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.chinacsr.com\/en\/#organization","name":"ChinaCSR.com","url":"https:\/\/www.chinacsr.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.chinacsr.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.chinacsr.com\/en\/wp-content\/uploads\/chinacsr-logo-large.jpg","contentUrl":"https:\/\/www.chinacsr.com\/en\/wp-content\/uploads\/chinacsr-logo-large.jpg","width":800,"height":620,"caption":"ChinaCSR.com"},"image":{"@id":"https:\/\/www.chinacsr.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/China_CSR"]},{"@type":"Person","@id":"https:\/\/www.chinacsr.com\/en\/#\/schema\/person\/144aee0ef9221d5da7dba67851ea5cba","name":"CSR and Sustainability Editor","sameAs":["http:\/\/www.chinacsr.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/posts\/1059","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/comments?post=1059"}],"version-history":[{"count":0,"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/posts\/1059\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/media?parent=1059"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/categories?post=1059"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chinacsr.com\/en\/wp-json\/wp\/v2\/tags?post=1059"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}